Exact Sciences Corp (EXAS):製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Exact Sciences Corp (EXAS) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10008
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:32
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Exact Sciences Corp (Exact Sciences) is a molecular diagnostic company that focuses on the early detection and prevention of various types of cancers. The company’s flagship product, Cologuard test is a non-invasive stool-based deoxyribonucleic acid (DNA) screening product indicated for the early detection of colorectal cancer and pre-cancer. It utilizes a multi-target approach to detect DNA and hemoglobin biomarkers associated with colorectal cancer. The company is also working on the development of additional tests for other types of cancers and identified proprietary methylation markers for several major cancers. It operates laboratory facilities in Madison, Wisconsin to process Cologuard tests. Exact Sciences is headquartered in Madison, Wisconsin, the US.

Exact Sciences Corp (EXAS) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Exact Sciences Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Exact Sciences Corp, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Exact Sciences Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Exact Sciences Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Exact Sciences Corp, Medical Devices Deals, 2012 to YTD 2018 9
Exact Sciences Corp, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Exact Sciences Corp, Pharmaceuticals & Healthcare, Deal Details 11
Venture Financing 11
Biomatrica Raises USD18.1 Million in Financing 11
Partnerships 12
Microbiologics Enters into Licensing Agreement with Biomatrica 12
Licensing Agreements 13
Biomatrica Enters Into Licensing Agreement With ATCC For DNAstable And RNAstable Reagents 13
Equity Offering 14
Exact Sciences Raises USD245 Million in Public Offering of Shares 14
Exact Sciences Prices Public Offering of Shares for USD178.5 Million 16
Exact Sciences Completes Public Offering Of Shares For US$146.6 Million 17
Exact Sciences Completes Public Offering Of Shares For US$78 Million 19
Exact Sciences Completes Public Offering of Common Stock For US$62 Million 20
Debt Offering 21
Exact Sciences Prices Public Offering of 1% Convertible Senior Notes Due 2025 for USD190 Million 21
Exact Sciences Raises USD690 Million in Public Offering of Senior Notes Due 2025 22
Exact Sciences Corp – Key Competitors 23
Exact Sciences Corp – Key Employees 24
Exact Sciences Corp – Locations And Subsidiaries 26
Head Office 26
Other Locations & Subsidiaries 26
Recent Developments 27
Strategy And Business Planning 27
Aug 14, 2018: University Research Park Breaks Ground on Corporate Headquarters Building for Exact Sciences 27
Financial Announcements 28
Oct 30, 2018: Exact Sciences announces third quarter 2018 financial results 28
Jan 07, 2018: Exact Sciences to report $265.5-266.5 million in revenue, 168 percent growth for 2017 29
Jul 25, 2017: Cologuard revenue increased to $57.6 million during second quarter; Test volume grew 149 percent from second quarter of 2016 to 135,000 completed tests 30
Feb 21, 2017: Exact Sciences reports lower Q4 net loss, provides outlook for 2017 31
Appendix 32
Methodology 32
About GlobalData 32
Contact Us 32
Disclaimer 32

List of Tables
Exact Sciences Corp, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Exact Sciences Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Exact Sciences Corp, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Exact Sciences Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Exact Sciences Corp, Deals By Therapy Area, 2012 to YTD 2018 8
Exact Sciences Corp, Medical Devices Deals, 2012 to YTD 2018 9
Exact Sciences Corp, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Biomatrica Raises USD18.1 Million in Financing 11
Microbiologics Enters into Licensing Agreement with Biomatrica 12
Biomatrica Enters Into Licensing Agreement With ATCC For DNAstable And RNAstable Reagents 13
Exact Sciences Raises USD245 Million in Public Offering of Shares 14
Exact Sciences Prices Public Offering of Shares for USD178.5 Million 16
Exact Sciences Completes Public Offering Of Shares For US$146.6 Million 17
Exact Sciences Completes Public Offering Of Shares For US$78 Million 19
Exact Sciences Completes Public Offering of Common Stock For US$62 Million 20
Exact Sciences Prices Public Offering of 1% Convertible Senior Notes Due 2025 for USD190 Million 21
Exact Sciences Raises USD690 Million in Public Offering of Senior Notes Due 2025 22
Exact Sciences Corp, Key Competitors 23
Exact Sciences Corp, Key Employees 24
Exact Sciences Corp, Subsidiaries 26

List of Figures
Exact Sciences Corp, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Exact Sciences Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Exact Sciences Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Exact Sciences Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Exact Sciences Corp, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Exact Sciences Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Exact Sciences Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Exact Sciences Corp, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[Exact Sciences Corp (EXAS):製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • NeuroMetrix Inc (NURO)-医療機器分野:企業M&A・提携分析
    Summary NeuroMetrix Inc (NeuroMetrix) is a medical device company that develops wearable medical technology and point of care test to manage chronic pain, nerve diseases, and sleep disorders. The company’s products include quell wearable pain relief device, SENSUS pain therapy device, NC-stat DPNChe …
  • Hydro-Electric Corporation:電力:M&Aディール及び事業提携情報
    Summary Hydro-Electric Corporation (Hydro Tasmania) is a state owned integrated energy utility. It generates electricity and supplies that on wholesale and retail basis. The company produces power using hydro, gas, wind and solar sources. Hydro Tasmania also retails gas to business and residential c …
  • Louis Dreyfus Company B.V.:企業の戦略的SWOT分析
    Louis Dreyfus Company B.V. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Alliance Data Systems Corp (ADS):企業の財務・戦略的SWOT分析
    Alliance Data Systems Corp (ADS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • Ana Holdings Inc
    Ana Holdings Inc - Strategy, SWOT and Corporate Finance Report Summary Ana Holdings Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Scholastic Corp (SCHL):企業の財務・戦略的SWOT分析
    Scholastic Corp (SCHL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Quorum Business Solutions Inc:石油・ガス:M&Aディール及び事業提携情報
    Summary Quorum Business Solutions Inc (QBS) is a technology company that develops, implements, and supports software solutions. The company offers software in the areas of accounting; transactions and logistics management; land, property and right of way management; liquid and gas measurement; energ …
  • MITIE Group plc (MTO):企業の財務・戦略的SWOT分析
    MITIE Group plc (MTO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Golden Meditech Holdings Ltd (801):企業の財務・戦略的SWOT分析
    Summary Golden Meditech Holdings Ltd (Golden Meditech) is a medical equipment provider that provides blood stem cells storage and hospital management solutions. The company provides autologous blood recovery systems. It offers hospital management, medical insurance administration and blood bank serv …
  • Barton Malow Company:戦略・SWOT・企業財務分析
    Barton Malow Company - Strategy, SWOT and Corporate Finance Report Summary Barton Malow Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Iridex Corp (IRIX)-医療機器分野:企業M&A・提携分析
    Summary Iridex Corp (IRIDEX) is a medical device company that manufactures and distributes laser-based medical systems, delivery devices and consumable instrumentation for the ophthalmology and otolaryngology market. The company provides products such as lasers, laser delivery devices, glaucoma devi …
  • Ivenix Inc-医療機器分野:企業M&A・提携分析
    Summary Ivenix Inc (Ivenix), formerly Fluidnet Corp is a medical technology company that offers infusion therapy solutions. The company offers products such as intravenous drug infusion pump systems and IV smart pump. Its IV smart pump eliminates air from fluid bag and IV lines to reduce number of a …
  • Colonial Pipeline Co:石油・ガス:M&Aディール及び事業提携情報
    Summary Colonial Pipeline Co (Colonial) is an oil and gas company that distributes petroleum products. The company transports refined petroleum products such as gasoline, home-heating oil, kerosene, diesel fuels; and aviation fuel including jet fuel and military fuels. It provides services including …
  • Multi-Color Corp (LABL):企業の財務・戦略的SWOT分析
    Summary Multi-Color Corp (Multi-Color) is a paper and packaging company that develops, manufactures and markets packaging labels. The company offers products such as self adhesive, RFID and NFC, decals and overlays, luminescent, membrane switches, nameplates and signage, foams and gaskets, domed lab …
  • Selective Insurance Group, Inc. (SIGI):企業の財務・戦略的SWOT分析
    Selective Insurance Group, Inc. (SIGI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths a …
  • Amneal Pharmaceuticals Inc (AMRX):製薬・医療:M&Aディール及び事業提携情報
    Summary Amneal Pharmaceuticals Inc (Amneal) formerly Amneal Pharmaceuticals LLC, is an integrated specialty pharmaceutical company that produces generic, specialty and biosimilar medicines. Its product portfolio includes generic and specialty drugs in the therapeutic areas of analgesic, antibiotic, …
  • Lear Corporation:企業の戦略・SWOT・財務分析
    Lear Corporation - Strategy, SWOT and Corporate Finance Report Summary Lear Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Tec-Masters, Inc.:企業の戦略・SWOT・財務情報
    Tec-Masters, Inc. - Strategy, SWOT and Corporate Finance Report Summary Tec-Masters, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Fresenius Medical Care AG & Co. KGaA:企業の戦略・SWOT・財務情報
    Fresenius Medical Care AG & Co. KGaA - Strategy, SWOT and Corporate Finance Report Summary Fresenius Medical Care AG & Co. KGaA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysi …
  • Tillotts Pharma AG:製薬・医療:M&Aディール及び事業提携情報
    Summary Tillotts Pharma AG (Tillotts) a subsidiary of Zeria Pharmaceutical Co Ltd is a healthcare solution provider that develops, licenses and markets pharmaceutical products, medical devices and diagnostics in the field of gastroenterology. The company’s products are used for the treatment of vari …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆